Founded in 1971, Sinclair is a global medical aesthetics company, that delivers an extensive product range. ​

​Our products are sold in more than 80 countries worldwide.​

​Since 2018 Sinclair has been a division of Huadong Medicine Ltd (HMC) which generated approximately $5.2 billion of revenue in 2022. HMC is an affiliate of China Grand Enterprises Inc. (CGE), an investment group headquartered in Beijing.​

​Sinclair has developed a portfolio of differentiated, complementary aesthetics technologies, targeting​,unmet clinical needs for effective, high-quality, long-lasting, natural-looking, and minimally-invasive​ treatments.. ​

​The Sinclair portfolio comprises 16 global brands, including 4 injectable fillers, 1 suspension thread device, and 11 energy-based devices (EBDs).